Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiotensin II Type 1 Receptor Blockers”

Showing 7 of 0 results

Large-scale testing (Phase 3)Study completedNCT00265642
What this trial is testing

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
ANRS, Emerging Infectious Diseases 166
Post-approval studies (Phase 4)Study completedNCT00126516
What this trial is testing

Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline

Who this might be right for
Brain InfarctionHypertension
Nara Medical University 395
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Not applicableUnknownNCT04510623
What this trial is testing

Host Response Mediators in Coronavirus (COVID-19) Infection

Who this might be right for
COVID-19SARS-CoV2
University of British Columbia 500
Post-approval studies (Phase 4)Study completedNCT00890591
What this trial is testing

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 144
Testing effectiveness (Phase 2)Ended earlyNCT02085265
What this trial is testing

Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Sunnybrook Health Sciences Centre 23
Not applicableUnknownNCT01444833
What this trial is testing

Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker

Who this might be right for
Hypertension
Slovak Academy of Sciences 35

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation